UT-MD Anderson Cancer Center: ASH - Triplet Combination Regimens Demonstrate High Response Rates in Multiple Leukemias
December 11, 2024
December 11, 2024
HOUSTON, Texas, Dec. 11 (TNSres) -- The University of Texas MD Anderson Cancer Center issued the following news release:
* * *
Three clinical trials yield strong results with undetectable measurable residual disease and overall response rates
ABSTRACTS: 216 (https://ash.confex.com/ash/2024/webprogram/Paper204375.html), 219 (https://ash.confex.com/ash/2024/webprogram/Paper200393.html), 1011 (https://ash.confex.com/ash/2024/webprogram/Paper211454.html)
. . .
* * *
Three clinical trials yield strong results with undetectable measurable residual disease and overall response rates
ABSTRACTS: 216 (https://ash.confex.com/ash/2024/webprogram/Paper204375.html), 219 (https://ash.confex.com/ash/2024/webprogram/Paper200393.html), 1011 (https://ash.confex.com/ash/2024/webprogram/Paper211454.html)
. . .